COVID-19 References

Additional References:

1. Trinidad & Tobago Ministry of Health: Charter of Patient’s Rights (No. 7 and No. 9): www.health.gov.tt/your-right-to-quality-service
   Archive.Today Web Capture of US National library of Medicine (nih.gov): Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease
2. ClinicalTrials.gov: COVID-19 Vaccine Messaging, Part 1 - Full Text View
3. ClinicalTrials.gov (Archived at archive.vn): Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults:- the AZD1222 (code name for Oxford–AstraZeneca COVID-19 vaccine) Phase III Double-blind, placebo-controlled study began on 28th August 2020 and is estimated to be completed on 21st February 2023.
   ClinicalTrials.gov (Archived at archive.vn): Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals:- the Pfizer/BioNTech SE study began on 29th April 2020 and is estimated to be completed on 31st January 2023.
   ClinicalTrials.gov (Archived at archive.vn): A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE)
4. FDA.gov: Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers: "“There is no FDA approved vaccine to prevent Covid-19”
   European Medicines Agency, AstraZeneca Product Information, Section 5.1: AstraZeneca authorized ONLY under a 1-year duration “Marketing Authorization (Conditional Approval)”: COVID-19 Vaccine AstraZeneca, COVID 19 Vaccine (ChAdOx1 S [recombinant])
   US Food & Drug Administration (FDA): FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
   Johnson & Johnson: Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use | Johnson & Johnson (jnj.com)
5. International Business Times, 16th March 2020: Vaccine skips important animal testing;
   Plant Based News, 20th March 2020: US Scientists fast track coronavirus vaccine;
   LiveScience.com, 13th March 2020: Researchers fast-track coronavirus vaccine by skipping key animal testing;
6. Science Direct: First case of postmortem study in a patient vaccinated against SARS-CoV-2 (... by postmortem molecular mapping, we found viral RNA in nearly all organs examined ... However, we did not observe any characteristic morphological features of COVID-19 .... Immunogenicity might be elicited, while sterile immunity was not established).
   (Also see the various Covid-19 vaccine product information sheet references above)
   Free West Media, 27th June 2020: "... Camilla Canepa was operated on by Gianluigi Zona, director of the neurosurgical and neuro-traumatological clinic of the San Martino hospital: “I had never seen a brain that was affected by such an extensive and severe thrombosis.”"
7. Insurance Journal, 14th August 2020: Drugmakers shielded from COVID vaccine liability;
   Sentinel Source, 29th March 2021, updated 5th May 2021: Vaccines experimental, with no liability, by John-Michael Dumais
8. Institute for Pure and Applied Knowledge (IPAK), Public Health PolicyInitiative (PHPI) - document at FileUsr.com: A report on the U.S Vaccine Adverse Effects Reporting System of the Covid-19 mRNA Biologicals;
   Centers for Disease Control & Prevention (CDC): CBER plans for monitoring COVID-19 vaccine safety and effectiveness
   Journal of Medical Clinical Research & Reviews, 24th March 2021 (PDF): Review of Covid-19 vaccines and the risk of chronic adverse events including neurological degeneration;
   C19 VAX REACTIONS - Home: Pro-Vaccine, pro-science Americans reporting on their serious COVID-19 Vaccine Injuries
9. European Medicines Agency's EudraVigilance: The (EU) system for managing and analysing information on suspected adverse reactions to medicines which have been authorised or being studied in clinical trials in the European Economic Area (EEA).
   The (UK) Medicines and Healthcare products Regulatory Agency (MHRA)'s Yellow Card scheme: MHRA  Yellow Card scheme collects and monitors information on suspected safety concerns or incidents involving: medicines, vaccines, medical devices, and e-cigarettes. The scheme relies on voluntary reporting of suspected safety concerns or incidents by healthcare professionals and members of the public (patients, users, or carers);
   VAERS COVID Vaccine Data: Reports from the (US) Vaccine Adverse Events Reporting System. Data reflects all (USA) VAERS data including (approx. 10%) the "nondomestic" reports;
   The Government of Canada: Canadian Adverse Events Following Immunization Surveillance System (CAEFISS)
10. Business Insider, 16th March 2021 (Link): Sweden joins Germany, France, and 15 other countries in suspending AstraZeneca's vaccine over possible side effects;
    FDA.gov, COVID-19 AstraZeneca Package Insert, Section 4.4: Thrombocytopenia and coagulation disorders;
    World Health Organisation (WHO): Review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield);
11. FDA.gov, updated 25 June 2021: Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers;
    European Medicines Agency: COVID-19 Vaccine AstraZeneca, COVID 19 Vaccine (ChAdOx1 S [recombinant]) Product Information as approved by the CHMP on 29 January 2021, pending endorsement by the European Commission along with E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION (see Page 15).
12. PubMed (nih.gov), March 2021: Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease
13. C19 Transparency Advocacy Group of Trinidad & Tobago (CTAGTT): https://c19-transparency-tt.org/
14. Open letter to the World Health Organization (WHO) by Geert Vanden Bossche, PhD Virology, DVM: Open letter; Geert Vanden Bossche website
    World Doctors Alliance: https://worlddoctorsalliance.com/
15. (US) National Center for Biotechnical Information | National Library of Medicine, National Institutes of Health: Predicting infectious SARS-COV-2 from diagnostic samples
    Oxford University Press | Oxford Academic | Clinical Infectious Diseases: To interpret the Sars-CoV-2 Test, Consider the Cycle Threshold Value
    YouTube.com  (VIDEO)| Kary Mullis was awarded the Nobel Prize for inventing the PCR test but he campaigned hard to stop it being used as a diagnostic test for HIV.  Same applied to why the PCR test shouldn't be used for mass testing covid-19. Karry Mullis (Inventor of PCR), explains why it is not a diagnostic tool
    U. S. CDC Centers for Disease Control & Prevention | Division of Laboratory Systems, 07/21/2021, Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing
16. StopWorldControl.com: CURES FOR COVID-19 - Confirmed by Medical Experts. Intro: "COVID-19 is not a death sentence, because there are cures for covid. Coronaviruses have existed for many decades and SARS-CoV-2 is just one of them. ... They are all categorized as influenza or flu viruses, which can be treated successfully."
    The ‘Front Line COVID-19 Critical Care Alliance (flccc.net): Hospital Treatment Protocol for COVID-19
    Directory of Doctors Prescribing Outpatient COVID-19 Therapy, updated 31st July 2021: https://www.exstnc.com/
17. Eurekalert | The American Association for the Advancement of Science (AAAS), 7th May 2021: Immediate global Ivermectin use will end Covid-19 Pandemic
    ResearchGate | The professional network for scientists and researchers, 30th June 2021: A continuation of a Timeline of Ivermectin-related events in the Covid-19 Pandemic
    American Journal of Therapeutics | Therapeutics Advances: Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
    SSRN.com | Searchable Open Access Online Research Library, 21st August 2020: ICON (Ivermectin in COvid Nineteen) Study: Use of Ivermectin Is Associated with Lower Mortality in Hospitalized Patients with COVID-19:
    Buffalo News, 15th January 2021: After judge orders hospital to use experimental Covid-19 treatment [Ivermectin], woman recovers
18. The Zelenko Protocol: Outpatient Study Finds that Combination of Zinc, Hydroxychloroquine, and Azithromycin Is Associated with Less Hospitalizations and Death for COVID-19 Patients
    ScienceDirect.com | Travel Medicine and Infectious Disease Volume 35, May–June 2020, 101738: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
    MedRxiv | The Preprint Server for Health Sciences: Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients ->>>> Completed, published study in Microbiology Society (MicrobiologyResearch.org): Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients with conclusion: "Zinc sulphate added to hydroxychloroquine and azithromycin associates with a decrease in mortality or transfer to hospice among patients who do not require ICU level of care and an increased likelihood to be discharged directly home from the hospital. ..."
    Henry Ford Health System: Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
    ScienceDirect.org | International Journal of Antimicrobial Agents Volume 56, Issue 1, July 2020, 105949: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
    Global Research | Centre for Research on Globalization: Open Letter to Dr. Anthony Fauci Regarding the Use of Hydroxychloroquine for Treating COVID-19
19. Orthomolecular Medicine News Service on ActiveHosted.com, July 18, 2020: COVID-19 - How can I cure thee? Let me count the ways

Compilation of Reference Sources (A - Z)

1. American Journal of Therapeutics | Therapeutics Advances
2. Business Insider
3. Canadian Adverse Events Following Immunization Surveillance System (CAEFISS)
4. C19 Vax Reactions
5. C19 Transparency Advocacy Group of Trinidad & Tobago
6. Directory of Doctors Prescribing Outpatient COVID-19 Therapy
7. EudraVigilance - EU database of suspected adverse drug reaction reports Adrreports.eu (in English)
8. Eurekalert | The American Association for the Advancement of Science (AAAS)
9. European Medicines Agency (EMA)
10. Free West Media - news site from Europe’s perspective
11. Front Line COVID-19 Critical Care Alliance
12. Geert Vanden Bossche
13. Henry Ford Health System
14. Institute for Pure and Applied Knowledge (IPAK) - Research via progressive science, a not-for-profit organization funded by private donations by the public
15. Insurance Journal
16. International Business Times
17. Johnson & Johnson
18. Journal of Medical - Clinical Research & Reviews
19. MedRxiv | The Preprint Server for Health Sciences
20. Microbiology Society
21. Ministry of Health (Trinidad & Tobago MoH)
22. Oxford Academic | Journals (oup.com)
23. Orthomolecular Medicine News Service
24. Plant Based News
25. Public Health Agency of Canada
26. PubMed (nih.gov)
27. ResearchGate | The professional network for scientists and researchers
28. Science Direct - Open access to peer-reviewed journal articles and book chapters (including open access content) of the Dutch publisher Elsevier
29. SSRN.com | Searchable Open Access Online Research Library
30. Stop World Control
31. The Zelenko Protocol
32. UK MHRA Yellow Card Reporting Scheme
33. U. S. CDC Centers for Disease Control & Prevention
34. U. S. Federal Drug Association (FDA)
35. U. S. ClinicalTrials.gov, by NLM at the NIH web-based clinical trials resource
36. U. S. National Center for Biotechnical Information | National Library of Medicine, National Institutes of Health
37. U. S. National Institutes of Health (NIH)
38. U. S. National Library of Medicine (NLM)
39. VAERS COVID Vaccine Data
40. World Doctors Alliance
41. World Health Organization